ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,639.20
      0.82%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.935
      0.57%
      Bitcoin
      59,632.93
      -3.86%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Cryptocurrencies
      4. COIN
      5. (Cryptocurrency:RYAGBP)

      6. (Cryptocurrency:RYAGBP) News

      RYAGBP

      (RYAGBP)

      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
      07/03/202412:05PMGlobeNewswire Inc.URW SE - Information on total number of voting rights and shares in the share capital as at June 30, 2024XE:1BR1Unibail Rodamco Westfield SE
      07/03/202412:05PMGlobeNewswire Inc.URW SE - Information on total number of voting rights and shares in the share capital as at June 30, 2024BIT:URWUnibail Rodamco Westfield SE
      07/03/202412:05PMGlobeNewswire Inc.URW SE - Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2024XE:1BR1Unibail Rodamco Westfield SE
      07/03/202412:05PMGlobeNewswire Inc.URW SE - Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2024BIT:URWUnibail Rodamco Westfield SE
      07/03/202412:05PMGlobeNewswire Inc.URW SE - Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2024TG:1BR1Unibail Rodamco Westfield SE
      07/03/202412:05PMBusiness WireResources Connection, Inc. to Announce Fourth Quarter and Full Fiscal Year 2024 Results on July 18, 2024NASDAQ:RGPResources Connection Inc
      07/03/202412:05PMGlobeNewswire Inc.URW SE - Information on total number of voting rights and shares in the share capital as at June 30, 2024TG:1BR1Unibail Rodamco Westfield SE
      07/03/202412:03PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
      07/03/202412:03PMBusiness WireHARMAN und CARIAD kündigen wachsendes Ökosystem mit neuen Apps in Fahrzeugen des Volkswagen-Konzerns an, die in den nächsten Wochen auf den Markt kommen
      07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesLSE:SHELShell Plc
      07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesEU:SHELLShell Plc
      07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesEU:SHELLShell Plc
      07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesTG:R6C0Shell Plc
      07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesLSE:SHELShell Plc
      07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesNYSE:SHELShell plc
      07/03/202412:02PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
      07/03/202412:01PMPR Newswire (US)National Western and Prosperity Life Group Announce Expected Closing Date for $1.9 Billion Cash MergerNASDAQ:NWLINational Western Life Group Inc
      07/03/202412:00PMGlobeNewswire Inc.Fly Play hf.: Rūta Dabašinskaitė-Vitkė Appointed New CFO of PLAY airlines  
      07/03/202412:00PMBusiness WireABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital socialEU:ABNXAbionyx Pharma
      07/03/202412:00PMGlobeNewswire Inc.Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371TG:6OPOSE Immunotherapeutics
      07/03/202412:00PMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim poursuivent l’avancée du développement clinique du traitement first-in-class SIRPα BI 770371 en immunologie du cancerEU:OSEOSE Immunotherapeutics
      07/03/202412:00PMGlobeNewswire Inc.Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371LSE:0RADOse Immunotherapeutics Sa
      07/03/202412:00PMGlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 1er juillet 2024LSE:0QSSPhaxiam Therapeutics
      07/03/202412:00PMBusiness WireABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share CapitalEU:ABNXAbionyx Pharma
      07/03/202412:00PMBusiness WireSergeFerrari Group : Bilan semestriel S1 2024 du contrat de liquidité avec la Société de Bourse Gilbert DupontEU:SEFERSergeferrari Group
      07/03/202412:00PMGlobeNewswire Inc.Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371EU:OSEOSE Immunotherapeutics
      07/03/202412:00PMGlobeNewswire Inc.Voltalia SA : Bilan semestriel du contrat de liquidité au 30 juin 2024LSE:0QW7Voltalia Sa
      07/03/202412:00PMGlobeNewswire Inc.Planisware - Total number of shares and voting rights end of june 2024EU:PLNWPlanisware SA
      07/03/202412:00PMBusiness WireHoffmann Green Cement Technologies : Bilan semestriel S1 2024 du contrat de liquidité confié à PORTZAMPARC – Groupe BNP PARIBASEU:ALHGRHoffmann Green Cement Technologies